A prospective study of prevalence & types of leprosy

Reddy G.A.1, Reddy G. N.2

1Dr. G. Adarsh Reddy, Assistant Professor, 2Dr. G. Narender Reddy, Associate Professor, both authors are affiliated with Department of Ophthalmology, MNR Medical College & Hospital, Sangareddy, Telangana, Andhra Pradesh, India.

Corresponding Author: G. Narender Reddy MS, DO, Associate Professor Department of Ophthalmology, MNR Medical College & Hospital, Sangareddy, Telangana, Andra Pradesh, India. E-mail:dradarshreddy26@gmail.com


Abstract

Introduction: Leprosy (Hansen disease) is a chronic infectious disease caused by an intracellular acid-fast bacillus Mycobacterium leprae which apart from skin, nasal mucosa and peripheral nerves also affects the anterior segment of the eye.M.leprae was discovered over a hundred years ago (around 1873) by Armauer Hansen. It is a disease that does not kill the affected individual but cripples. When the threat of blindness is also added to patient’s natural dread of the disease, the condition is indeed terrifying.Materials and methods: This study comprises of detailed examination of 180 consecutive patients of Hansen's disease. It has been carried out in the Department of Ophthalmology, Mamata General Hospital, Khammam and with the cooperation of department of Dermatology, Mamata General Hospital.Allpatients who were admitted inthe leprosy department with leprosy from 2015 January to December 2016 December were included in this study.All the patients withcongenital abnormalities, inflammatory conditions of the breast and breast carcinomas were excludedfrom the study.Results: This study includes a total number of 180 patients of leprosy disease who were carefully examined for any evidence of ocular lesion. Most of the patients were males, females accounting for only 21.79%. Among the 180 patients, 60 patients had the evidence of the ocular involvement. It points out to the fact that most of the Hansen's patients develop ocular lesions.Conclusion: Most of the patients are adults. There is no significant influence of age either on the presence or absence of eye involvement or in the type of Hansen's disease.The commonest type of leprosy is lepromatous leprosy followed by all types of borderline leprosy. The incidence of ocular involvement is very high in these two forms of leprosy disease (86.6%& 63.6%).

Key words: Hansens disease, Lepromatous leprosy, Leprosy


Manuscript received: 10th January 2019 Reviewed: 20th January 2019 

Author Corrected: 28th January 2019 Accepted for Publication: 2 nd February 2019

Introduction

Leprosy (Hansen disease) is a chronic infectious disease caused by an intracellular acid-fast bacillus Mycobacterium leprae which apart from skin, nasal mucosa and peripheral nerves also affects the anterior segment of the eye[1].M.leprae was discovered over a hundred years ago (around 1873) by Armauer Hansen. It is a disease that does not kill the affected individual but cripples. When the threat of blindness is also added to patient’s natural dread of the disease, the condition is indeed terrifying. There is direct ocular involvement in lepromatous type, whereas in tuberculoid type ocular involvement is indirect. The eyes can also be involved in lepra reactions [2].Ocular lesions are common in lepromatous type taking the form of lepromatous nodules, conjunctivitis, keratitis, pannus, scleritis and uveitis.In tuberculoid type, ocular lesions are rare. They are secondary to involvement of branches of seventh cranial nerve giving rise to paralytic lagophthalmos and exposure keratitis and involvement of trigeminal nerve leading to neurotrophic keratitis. Acute iridocyclitis and scleritis most commonly occur during type II lepra reactions which occur in lepromatous type of leprosy[3,4,5].In leprosy, the hands and feet have received a tremendous amount of attention however by comparison eyes have been neglected. An attempt should be made to educate these patients to undergo regular eye examination. Much of the ocular morbidity and blindness due to leprosy are potentially avoidable by screening, detection and early treatment of the potentially sight threatening lesions [6,7,8].

Leprosy is a disease of great antiquity having been recognized from Vedic times in India and from Biblical times in the Middle East. It probably originated in the tropics & spread to the rest of the world [9,10].In this study we are going to study the prevalence of leprosy in general hospital, Khammam.

Materials and Methods

This study comprises of detailed examination of 180 consecutive patients of Hansen's disease. It has been carried out in the Department of Ophthalmology, Mamata General Hospital, Khammam and with the cooperation of department of Dermatology, Mamata General Hospital.

Inclusion criteria: All patients who were admitted inthe leprosy department with leprosy from 2015 January to December 2016 were included in this study.

Exclusion Criteria:All the patients withcongenital abnormalities, inflammatory conditions of the breast and breast carcinomaswere excludedfrom the study.

Clinical records of all the patients of Leprosy attending leprosy Clinic, in OPD of the department of Dermatology, Venereology and Leprosy, for a period of two years, from January 2015 to December 2016, were analyzed, after obtaining institutional ethical clearance and anonym sing the data. The Clinical records of patients provided information on demographic data, details of clinical examination, type of Leprosy, complications like Lepra reactions, deformities, trophic ulcers and treatment.Patients were classified according to Ridley Jopling classification. Two more categories, indeterminate leprosy (I) and primary neuritic leprosy, were added. For the purpose of MDT, the disease was classified into multibacillary (MB), if there were six or more lesions and/or more than one nerve involvement, as per WHO classification. The diagnosis was mostly clinical and made by consultants with postgraduate qualification in Dermatology,Venereology and Leprosy. Slit skin smear examinations and lesional biopsy were done, wherever needed, for confirmation of diagnosis.

Statistical Analysis:Descriptive statistics like mean and percentages were used to interpret the data with the help of Microsoft office 2007.

Results

In our study 180 leprosy patients were examined, In that 140 (78.2%) patients were males, 40 (21.79%) were females. This study includes a total number of 180 patients of leprosy disease who were carefully examined for any evidence of ocular lesion. Most of the patients were males, females accounting for only 21.79%. Among the 180 patients, 60 patients had the evidence of the ocular involvement comprising 76.9% of patients. It points out to the fact that most of the Hansen's patients develop ocular lesions.

Table-1: Age Incidence

Type

Total

0-10

11-20

21-30

31-40

41-50

51-60

61-70

LL

87

-

-

4

12

19

8

4

BL

37

-

2

2

1

3

4

2

BB

29

-

-

2

5

2

-

-

BT

18

-

-

1

1

2
-

-

-

-

TT

9

-

1

1

2

 

-

 

Total

180

-

10

23

47

60

22

18

Table-2: ACE Incidence with ocular lesions

Type

Total

 

0-10

 

11-20

 

21-30

 

31-40

 

41-50

 

51-60

 

61-70

 

 

 

LL

117

-

-

6

24

48

27

12

BL

36

-

-

6

6

6

12

6

BB

9

-

-

3

-

6

-

-

BT

9

-

-

3

3

3

-

-

TT

12

-

-

6

3

-

-

-

Total

180

-

-

24

36

63

36

18

Most of the Patients examined are adults. Only three patients are below the age of 20 years. There is no significant difference in the age distribution of patients of Hansen's disease as compared to that of patients with ocular involvement. None out of 3 patients below the age of 20 years had ocular manifestations. Similarly, there is no significant variation in the distribution in different types of leprosy disease.

Alternate

Figure-1: Prevalence of types of leprosy

 

Table-3: Sex Incidence

Type

Male

Percent

Female

Percent

LL

85

47.43%

22

10.25%

BL

27

15.38%

6

2.56%

BB

12

6.4%

8

5.14%

BT

5

2.56%

4

3.86%

TT

12

6.4%

-

-

Total

141

78.19%

40

21.77%

Most of the patients examined are males, who outnumbered females in the ratio of 3:1 approximately with 61 patients being males and only 17 being females. This ratio is maintained in lepromatous leprosy and border line lepromatous type of leprosy disease. But in borderline and borderline tulerculoid type of leprosy the ratio is 1:1; though its significance is of doubtful because of the smallness of number.

Table-3: Incidence of types of leprosy

Type

Total

Ocular lesion

Percent

LL

87

75

86.6%

BL

37

31

85.71%

BB

29

10

33.3%

BT

18

10

60%

TT

9

6

60%

Hansen's disease 'has been clinically classified into 3 types, lepromatous leprosy (LL), tuberculoid leprosy (TT) and borderline type. The borderline is again sub-divided into 3 types i.e., borderline lepromatous leprosy (BL), border­line (BB) and border line tuberculoid type of leprosy (BT).

Among the 78 patients examined, 45 patients (86.6%) belonged to lepromatous type of leprosy and only 5(6.4%) belonged to tuberculoid type of leprosy. Among the borderline group also majority belonged to borderline lepromatous leprosy (BL) and only 5 belonged to borderline tuberculoid type of leprosy (BT). The overall incidence of lepromatous type is much more than that of tuberculoid type.

In the present study, the ocular involvement is 86.6% in lepromatous leprosy, 63.6% in Border line type of leprosy (85.7% in BL, 33.3% in BB, 60% in BT) and 60% in tuberculoid leprosy. The incidence is higher in lepromatous leprosy and BL type of leprosy.

Discussion

Ina study conducted by A Samuel Gnanadoss, N Rajendran in 250patients of leprosy. cases were analysed.Out of them, 102 cases (40.8%) were lepro­matous, 96 (38.3%) were tuberculoid and 52 were (20.8%) borderline cases[11].

In our study, among the 180 patients examined, 155 patients (86.6%) belonged to lepromatous type of leprosy and only 12(6.4%) belonged to tuberculoid type of leprosy. Among the borderline group also majority belonged to borderline lepromatous leprosy (BL) and only 5 belonged to borderline tuberculoid type of leprosy (BT). The overall incidence of lepromatous type is much more than that of tuberculoid type.

In the study conducted by A Samuel Gnandoss, N Rajendran, Since Hansen's is a chronic condition it is not surprising to see that 52% were above the age of 40 years[12].

In our study, Most of the Patients examined were adults. Only three patients are below the age of 20 years. There is no significant difference in the age distribution of patients of Hansen's disease as compared to that of patients with ocular involvement.

In our study, the ocular involvement is 86.6% in lepromatous leprosy, 63.6% in Border line type of leprosy (85.7% in BL, 33.3% in BB, 60% in BT) and 60% in tuberculoid leprosy. The incidence is higher in lepromatous leprosy and BL type of leprosy.

In astudy conducted by shivyogi R. Kusagar on ocular manifestations in leprosy, Among the three major types of leprosy, all were found to have ocular changes. Ocular involvement was predominantly seen in lepromatous type (35%), followed by Borderline lepromatous type (31%),and borderline tuberculoid, and tuberculoid type (17% each respectively)[13,14,15,16,17].

This was similar to study by Wani M.S. et al, wherein ocular involvement was found to be higher in lepromatous leprosy (75.36 %), followed by borderline (14.49 %) and tuberculoid leprosy (10.14%). Ocular complications appear to be more common among lepromatous patients than tuberculoid as anterior segment of the eye provides a favorable environment for the M. Leprae which is more numerous in the lepromatous patients. All the 24 % of patients with history of lepra reaction in the study group, showed ocular manifestations[18-22].

Conclusion

Most of the patients are adults. There is no significant influence of age either on the presence or absence of eye involvement or in the type of Hansen's disease. Most of the patients are males who outnumbered females in the ration of 3:1. This difference is seen in all the types of Hansen's disease. The commonest type of leprosy is lepromatous leprosy followed by all types of borderline leprosy. The incidence of ocular involvement in very high in thesetwo forms of leprosy disease (86.6%& 63.6%).

References

1. Salodkar AD, Kalla G. A clinic-epidemiological study of leprosy in arid North west Rajasthan, Jodhpur. Ind J Lepr. 1995;57:161–6.[pubmed]

2. Sharma A, Sharma RK, Goswsami KC, Bardwaj S. Clinico-Histopathological Correlation in Leprosy. JK Science. 2008;10:120–3.

3. Shenoi SD, Siddappa K. Correlation of clinical and histopathologic features in untreated macular lesions of leprosy: A study of 100 cases. Ind J Lepr. 1988;60:202–6.

4. Nadkarni NS, Rege VL. Significance of histopathological classification in leprosy. Ind J Lepr. 1999;7:325–32.[pubmed]

5. Moorthy BN, Kumar P, Chatura KR, Chandrasekhar HR, Basavaraja PK. Histopathological correlation of skin biopsies in leprosy. Ind J Dermatol Ven Leprol. 2001;67:299–301.[pub med]

6. V Pannikar VK, Arunthathi S, Chacko CJ, Fritschi EP. A clinicopathological study of primary neuritic leprosy. Ind J Lepr. 1983;55:212–21.[pubmed]

7. Jacob M, Arunthathi S. The Wague; 1988. A study of primary neuritic leprosy (Abst): In Proc XIII Int LepCongr (September 11-17) p. 313.

8. Girdhar BK. Neuritic leprosy. Indian J Lepr. 1996;68:35–42.[pubmed]

9. Enhanced Global Strategy for Further Reducing the Disease Burden due to Leprosy (Plan Period: 2011-2015) World Health Organization, SEA-GLP-2009.3

10. Singh K, Iyengar B, Singh R. Variation in clinical and histopathological classification of leprosy: A report and plausible explanation. Lepr India. 1983;55:472–9.

11. Kalla G, Salodkar A, Kachhawa D. Clinical and histopathological correlation in leprosy. Int J Lepr. 2000;68:184–5.[pubmed]

12. Shanker Narayan NP, Ramu G, Desikan KV, Vallishayee RS. Correlation of clinical, histological and immunological features across the leprosy spectrum. Ind J Lepr. 2001;73:329–42.

13. Singhi MK, Kachhawa D, Ghiya BC. A retrospective study of clinico-histological correlation in leprosy. Ind J Pathol Microbiol. 2003;46:47–8.

14. Kaur S, Sharma VK, Basak P, Kaur I. Paucibacillary multidrugtherapy in leprosy: 7 1/2 year experience. Ind J Lepr. 1992;64:153–61.[pubmed]

15. Singh RP, Tiwari VD, Chattopadhyay SP. Comparative study of short-term results in two multidrug regimens in MB leprosy. Ind J Lepr. 1993;65:173–80.[pubmed]

16. Kishore BN, Shetty JN. Bacterial clearance with WHO recommended MDR for MB leprosy. Ind J Lepr. 1995;67:301–8.[pubmed]

17. Shivayogi R. Kusagur, Mamatha S. Kusagur, Gururaj K. J. “A clinical study of ocular manifestations in leprosy”. Journal of Evolution of Medical and Dental Sciences 2013; Vol2, Issue 36, September 9; Page: 6816-6823.

18. Lewallen, Paul Courtright. An overview of ocular leprosy after 2 decades of multidrug therapy. International ophthalmology clinics – world blindness. Sep 2004, Vol-47; No. (3):8799.

19. Sihota. Tandon Disease of the uveal tract chapter 17. Parsons disease of the eye 20thedn. New Delhi Elsevier 2007; 239-72.

20. Dr. MargreetHogeweg, Dr Murray McGavin, Prevention of Blindness Due To Leprosy. ICEH, http://www.iceh.org.uk.Indian association of Leprologists-approved classification. Lepr India. 1982;54:22–32.

21. WHO Tech Rep Ser 675. Geneva: WHO; 1982. World Health Organizion. Chemotherapy of leprosy for control programmes. Geneva: WHO; 1988. WHO Expert Committee Report on Leprosy. Sixth Report. TRS 768.

22. Sachdeva S, Amin SS, Khan Z, Alam S, Sharma PK. Childhood leprosy: A retrospective study. J Public Health Epidemiol. 2010;2:267–71.


How to cite this article?

Rajeshkannan R., Venkatesan M.J., Ezhilvendhan K., Rao A.V.R. A study to compare the conjunctival flora of nondiabetic individuals with that of diabetic patients. Ophthal Rev: Tro J ophtha & Oto. 2019;4(1): 60-64. doi: 10.17511/ jooo.2019.i1.12